Health
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
Today's Big Question -
Kidney stones are affecting children far more than they once did
Under the radar Salt may be to blame
By Devika Rao, The Week US Published
Under the radar -
Naltrexone: the wonder drug for alcoholism
The pill is said to have a high success rate in reducing alcohol cravings with few side effects
By Richard Windsor, The Week UK Published
-
'Restricting what an agent can know and respond to reduces its competitiveness'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
Instant Opinion -
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
The Explainer -
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
The explainer -
How can the UK solve the adult social care crisis?
Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
By Elizabeth Carr-Ellis, The Week UK Published
Today's Big Question -
Can you prevent a hangover?
Talking Point Over half of us will drink more than usual this month, but there are ways to minimise the effects of alcohol on the morning after
By Adrienne Wyper, The Week UK Published
Talking Point -
Five medical breakthroughs of 2024
The Explainer The year's new discoveries for health conditions that affect millions
By Adrienne Wyper, The Week UK Published
The Explainer -
Are pig-organ transplants becoming a reality?
The Explainer US woman has gene-edited pig-kidney transplant, and scientists hope experimental surgery could save thousands of lives
By Abby Wilson Published
The Explainer -
Why are people microdosing Ozempic?
In The Spotlight Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a good idea?
By Chas Newkey-Burden, The Week UK Published
In The Spotlight -
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
In the Spotlight -
4 tips for navigating holiday season stress
The Week Recommends Balancing pressure and enjoying the holidays can indeed coexist
By Theara Coleman, The Week US Published
The Week Recommends -
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
Under the radar